Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1923]
News [3529]
Articles [90]
Editorials [5]
Conferences [156]
elearning [19]
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of...
Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients ( Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA )
4 Nov 2020
The ENA virtual meeting 2020
Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
The ENA virtual meeting 2020 ( Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation
Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation ( Dr Pasi Janne - Dana Farber Cancer Institute, Boston, USA )
4 Nov 2020
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1...
Dr Julius Strauss - National Institutes of Health, Bethseda, USA
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy ( Dr Julius Strauss - National Institutes of Health, Bethseda, USA )
4 Nov 2020
OncoAlert and ecancer weekly roundup for October 26 - 31, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 26 - 31, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
2 Nov 2020
OncoAlert and ecancer weekly roundup for October 19-26, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 19-26, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
28 Oct 2020
OncoAlert and ecancer weekly roundup for October 12 - 18, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 12 - 18, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
23 Oct 2020
OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
12 Oct 2020
Neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer
Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer ( Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
6 Oct 2020
OncoAlert and ecancer weekly roundup for September 27 - October 4th, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for September 27 - October 4th, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
6 Oct 2020
Management of infection risk to myeloma patients during the COVID pandemic
Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology...
Management of infection risk to myeloma patients during the COVID pandemic ( Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria )
1 Oct 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation